# Atreca Stock Financials

BCEL Stock | USD 1.58 0.00 0.00% |

**M**this year, although the value of Net Income Per Employee will most likely fall to (1

**M**).

Atreca | Select Account or Indicator |

With this module, you can analyze Atreca financials for your investing period. You should be able to track the changes in Atreca individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

### Atreca Most Recent Estimates

EPS Estimate Next Quarter(0.64) | Diluted Eps(2.90) | EPS Estimate Current Year(2.57) | EPS Estimate Next Year(2.12) | EPS Estimate Current Quarter(0.73) |

Understanding current and past Atreca Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Atreca's financial statements are interrelated, with each one affecting the others. For example, an increase in Atreca's assets may result in an increase in income on the income statement.

## Total Debt | ## 3,694.74 |

The financial analysis of Atreca is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Atreca includes many different criteria found on its balance sheet. For example, investors should never minimize Atreca's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Atreca's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Atreca.

### Atreca Inc Cash

Chance Of Financial Distress

Less than 48

Atreca Inc has

**less than 48 (%) percent**chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Atreca stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More InfoThe data published in Atreca's official financial statements usually reflect Atreca's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Atreca Inc. For example, before you start analyzing numbers published by Atreca accountants, it's critical to develop an understanding of what Atreca's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.

Please note, the presentation of Atreca's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Atreca's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Atreca's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Atreca Inc. Please utilize our Beneish M Score to check the likelihood of Atreca's management to manipulate its earnings.

## Atreca Company Summary

Atreca competes with Agilent Technologies, Acasti Pharma, Adaptimmune Therapeutics, AstraZeneca PLC, and Cocrystal Pharma. Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |

Instrument | USA Stock View All |

Exchange | NASDAQ Exchange |

CIK Number | 0001532346 |

ISIN | US04965G1094 |

Region | North America |

Business Address | 835 Industrial Road, |

Sector | Biotechnology |

Industry | Health Care |

Benchmark | NYSE Composite |

Website | www.atreca.com |

Phone | 650 595 2595 |

Currency | USD - US Dollar |

You should never invest in Atreca without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Atreca Stock, because this is throwing your money away. Analyzing the key information contained in Atreca's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

## Atreca Key Financial Ratios

Generally speaking, Atreca's financial ratios allow both analysts and investors to convert raw data from Atreca's financial statements into concise, actionable information that can be used to evaluate the performance of Atreca over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Atreca Inc reports annually and quarterly.Return On Asset | (0.34) % | |||

Price to Earning | (3.53) X | |||

Price to Book | 0.40 X |

## Atreca Key Balance Sheet Accounts

2018 | 2019 | 2020 | 2021 | 2022 | 2023 (projected) | ||

Accounts Payable | 1.31 M | 2.13 M | 5.22 M | 3.35 M | 3.02 M | 2.65 M | |

Total Assets | 121.68 M | 195.72 M | 272.06 M | 200.06 M | 180.05 M | 164.29 M | |

Current Assets | 117.22 M | 176.12 M | 249.12 M | 122.37 M | 110.13 M | 116.64 M | |

Assets Non Current | 4.46 M | 19.6 M | 22.94 M | 77.69 M | 89.34 M | 96.39 M | |

Cash and Equivalents | 114.5 M | 157.95 M | 60.79 M | 94.75 M | 85.27 M | 81.62 M | |

Shareholders Equity | 116.64 M | 186.95 M | 242.06 M | 154.93 M | 139.44 M | 135.15 M | |

Total Liabilities | 5.05 M | 8.76 M | 30.01 M | 45.13 M | 40.62 M | 43.82 M | |

Current Liabilities | 4.56 M | 7.95 M | 17.42 M | 16.9 M | 15.21 M | 12.18 M |

## Atreca Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Atreca's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.

2018 | 2019 | 2020 | 2021 | 2022 | 2023 (projected) | ||

Consolidated Income | (37.94 M) | (67.48 M) | (86.33 M) | (109.33 M) | (98.39 M) | (106.16 M) | |

Earning Before Interest and Taxes EBIT | (37.93 M) | (67.48 M) | (86.33 M) | (109.32 M) | (98.39 M) | (106.16 M) | |

Earning Before Interest and Taxes USD | (37.93 M) | (67.48 M) | (86.33 M) | (109.32 M) | (98.39 M) | (106.16 M) | |

Interest Expense | 9 K | 6 K | 4 K | 3 K | 2.7 K | 2.77 K | |

Net Income | (37.94 M) | (67.48 M) | (86.33 M) | (109.33 M) | (125.72 M) | (135.65 M) | |

Net Income Common Stock | (37.94 M) | (67.48 M) | (86.33 M) | (109.33 M) | (98.39 M) | (106.16 M) | |

Net Income Common Stock USD | (37.94 M) | (67.48 M) | (86.33 M) | (109.33 M) | (98.39 M) | (106.16 M) | |

Operating Expenses | 39.57 M | 72.57 M | 88.88 M | 110.3 M | 126.85 M | 106.22 M | |

Operating Income | (39.57 M) | (72.57 M) | (88.88 M) | (110.3 M) | (99.27 M) | (107.11 M) | |

Research and Development Expense | 32.51 M | 54.73 M | 62.05 M | 78.35 M | 90.1 M | 76.66 M | |

Selling General and Administrative Expense | 7.06 M | 17.84 M | 26.83 M | 31.95 M | 36.75 M | 29.56 M | |

Weighted Average Shares | 2.1 M | 15.83 M | 31.92 M | 37.04 M | 33.33 M | 35.97 M | |

Weighted Average Shares Diluted | 2.1 M | 15.83 M | 31.92 M | 37.04 M | 33.33 M | 35.97 M |

## Atreca Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Atreca Inc. It measures of how well Atreca is doing because it can show the actual money that comes into and out of the company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Atreca brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Atreca had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Atreca has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.

2018 | 2019 | 2020 | 2021 | 2022 | 2023 (projected) | ||

Capital Expenditure | (1.76 M) | (3.45 M) | (5.03 M) | (35.09 M) | (31.58 M) | (32.41 M) | |

Depreciation Amortization and Accretion | 1.41 M | 1.7 M | 2.38 M | 4.55 M | 5.23 M | 5.65 M | |

Net Cash Flow or Change in Cash and Cash Equivalents | 106.26 M | 44.73 M | (96.8 M) | 33.76 M | 30.39 M | 32.79 M | |

Issuance Purchase of Equity Shares | 46 K | 134.07 M | 129.55 M | 5.5 M | 6.32 M | 6.49 M | |

Net Cash Flow from Financing | 120.3 M | 131.17 M | 128.87 M | 5.45 M | 6.26 M | 6.43 M | |

Net Cash Flow from Investing | 20.66 M | (27.9 M) | (159 M) | 89.24 M | 80.31 M | 86.65 M | |

Net Cash Flow Investment Acquisitions and Disposals | 22.42 M | (24.46 M) | (153.97 M) | 124.33 M | 142.98 M | 154.26 M | |

Net Cash Flow from Operations | (34.7 M) | (58.54 M) | (66.67 M) | (60.92 M) | (70.06 M) | (75.59 M) | |

Share Based Compensation | 1.42 M | 6.06 M | 12.48 M | 16.88 M | 19.41 M | 20.94 M |

## Atreca Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Atreca's current stock value. Our valuation model uses many indicators to compare Atreca value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atreca competition to find correlations between indicators driving Atreca's intrinsic value. More Info.Atreca Inc is rated**third**in cash per share category among related companies. It is rated

**third**in current ratio category among related companies fabricating about 3.08 of Current Ratio per Cash per Share. Atreca Current Ratio is relatively stable at the moment as compared to the past year. The company's current value of Current Ratio is estimated at 8.55. Comparative valuation analysis is a catch-all model that can be used if you cannot value Atreca by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Atreca's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Atreca's earnings, one of the primary drivers of an investment's value.

## Atreca Inc Systematic Risk

Atreca's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Atreca volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.

The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Beta measures systematic risk based on how returns on Atreca Inc correlated with the market. If Beta is less than 0 Atreca generally moves in the opposite direction as compared to the market. If Atreca Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Atreca Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Atreca is generally in the same direction as the market. If Beta > 1 Atreca moves generally in the same direction as, but more than the movement of the benchmark..

## About Atreca Financials

What exactly are Atreca Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Atreca's income statement, its balance sheet, and the statement of cash flows. Potential Atreca investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Atreca investors may use each financial statement separately, they are all related. The changes in Atreca's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Atreca's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Atreca is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Atreca has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

## Atreca January 27, 2023 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Atreca help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Atreca Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Atreca Inc based on widely used predictive technical indicators. In general, we focus on analyzing Atreca Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Atreca's daily price indicators and compare them against related drivers.

Downside Deviation | 6.54 | |||

Information Ratio | 0.0215 | |||

Maximum Drawdown | 37.53 | |||

Value At Risk | (9.49) | |||

Potential Upside | 12.63 |

Continue to Trending Equities. Note that the Atreca Inc information on this page should be used as a complementary analysis to other Atreca's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

## Complementary Tools for Atreca Stock analysis

When running Atreca Inc price analysis, check to measure Atreca's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atreca is operating at the current time. Most of Atreca's value examination focuses on studying past and present price action to predict the probability of Atreca's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atreca's price. Additionally, you may evaluate how the addition of Atreca to your portfolios can decrease your overall portfolio volatility.

Fundamental Analysis View fundamental data based on most recent published financial statements | |

Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |

Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |

My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |

Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |

Equity Valuation Check real value of public entities based on technical and fundamental data | |

Volatility Analysis Get historical volatility and risk analysis based on latest market data | |

Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |

Is Atreca's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atreca. If investors know Atreca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atreca listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Market Capitalization61.7 M | Return On Assets(0.34) | Return On Equity(0.78) |

The market value of Atreca Inc is measured differently than its book value, which is the value of Atreca that is recorded on the company's balance sheet. Investors also form their own opinion of Atreca's value that differs from its market value or its book value, called intrinsic value, which is Atreca's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atreca's market value can be influenced by many factors that don't directly affect Atreca's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Atreca's value and its price as these two are different measures arrived at by different means. Investors typically determine Atreca value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atreca's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.